| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;107:2153.)
© 2003 American Heart Association, Inc.
Basic Science Reports |
From the Cardiovascular Research Institute, Washington Hospital Center, and the Armed Forces Institute of Pathology (M.C.J., R.V.), Washington, DC.
Correspondence to Ron Waksman, MD, Washington Hospital Center, 110 Irving St, NW, Suite 4B-1, Washington, DC 20010. E-mail ron.waksman{at}medstar.net
Background Late total occlusion after vascular brachytherapy (VBT) continues to be a serious complication. Delayed reendothelialization was suggested as a pivotal cause, but the time course for complete healing is unknown.
Methods and Results Seventy-two rabbit iliac arteries underwent stent implantation and were treated with
-radiation using 192Ir. The prescribed doses were 0 Gy (controls, n=24 arteries), 15 Gy (n=24), or 30 Gy (n=24) at 2 mm. Animals were killed at 1 month (n=24), 3 months (n=24), or 6 months (n=24) and were analyzed for histomorphometry or scanning electron microscopy. Intimal area was reduced after VBT at 3 months with 15 and 30 Gy (0.66±0.07 and 0.66±0.04 mm2, respectively) compared with controls (1.01±0.11 mm2, P<0.05) and at 6 months with 30 Gy (0.75±0.09 versus 1.28±0.26 mm2 in controls, P<0.01). Intimal area was similar at 6 months between 15 Gy and controls. At 1 month, 92±4% of the control stented segment was covered with endothelial cells, whereas only 37±4% and 37±8% was covered in the 15- and 30-Gy arteries, respectively. Similarly, at 3 and 6 months, there was a difference in the extent of reendothelialized areas (at 3 months, 95±2%, 32±12%, and 29±13%; and at 6 months, 98±2%, 40±8%, and 35±12% in control, 15-Gy, and 30-Gy arteries, respectively). Excess platelets and leukocytes were seen in irradiated arteries without complete coverage of endothelium.
Conclusions Reendothelialization after VBT is not completed at 6 months after VBT. Special care with prolonged antiplatelet therapy should be considered beyond that time point.
Key Words: brachytherapy stent endothelium thrombosis
This article has been cited by other articles:
![]() |
F. Sera, M. Awata, M. Uematsu, J.-i. Kotani, S. Nanto, and S. Nagata Optimal Stent-Sizing With Intravascular Ultrasound Contributes to Complete Neointimal Coverage After Sirolimus-Eluting Stent Implantation Assessed by Angioscopy J. Am. Coll. Cardiol. Intv., October 1, 2009; 2(10): 989 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Mintz and S.-Y. Choi Optimal Stent Expansion and Complete Neointimal Coverage: Does This Association Make Sense? J. Am. Coll. Cardiol. Intv., October 1, 2009; 2(10): 995 - 996. [Full Text] [PDF] |
||||
![]() |
F. Gomez, W. Escobar, A.M. Gomez, J.F. Gomez, and C.A. Anaya Treatment of Carotid Cavernous Fistulas Using Covered Stents: Midterm Results in Seven Patients AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1762 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Finn, G. Nakazawa, M. Joner, F. D. Kolodgie, E. K. Mont, H. K. Gold, and R. Virmani Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1500 - 1510. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Waksman, I M Leitch, J Roessler, H Yazdi, R Seabron, F Tio, R W Scott, R I Grove, S Rychnovsky, B Robinson, et al. Intracoronary photodynamic therapy reduces neointimal growth without suppressing re-endothelialisation in a porcine model Heart, August 1, 2006; 92(8): 1138 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Kotani, M. Awata, S. Nanto, M. Uematsu, F. Oshima, H. Minamiguchi, G. S. Mintz, and S. Nagata Incomplete Neointimal Coverage of Sirolimus-Eluting Stents: Angioscopic Findings J. Am. Coll. Cardiol., May 16, 2006; 47(10): 2108 - 2111. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Schwartz, E. R. Edelman, For the Consensus Committee, A. Carter, N. A. Chronos, C. Rogers, K. A. Robinson, R. Waksman, L. Machan, J. Weinberger, et al. Preclinical Evaluation of Drug-Eluting Stents for Peripheral Applications: Recommendations From an Expert Consensus Group Circulation, October 19, 2004; 110(16): 2498 - 2505. [Full Text] [PDF] |
||||
![]() |
P. W. Serruys, W. Wijns, G. Sianos, I. de Scheerder, P. A. van den Heuvel, W. Rutsch, H. D. Glogar, C. Macaya, P. H. Materne, S. Veldhof, et al. Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: Results of a randomized trial: Beta-radiation Investigation with Direct stenting and Galileo in Europe (BRIDGE) J. Am. Coll. Cardiol., August 4, 2004; 44(3): 528 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Togni, S. Windecker, P. Wenaweser, D. Tueller, A. Kaisaier, W. Maier, B. Meier, and O. M. Hess Deleterious Effect of Coronary Brachytherapy on Vasomotor Response to Exercise Circulation, July 13, 2004; 110(2): 135 - 140. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |